Financial Information | Regeneron Pharmaceuticals Inc.

Filing date	Form	Description	View
Jan 11, 2023	SC 13G	A statement of beneficial ownership of common stock by certain persons	View HTML 0000019617-23-000061.pdf 0000019617-23-000061.xls
Jan 10, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-23-000025.pdf 0001883850-23-000025.xls
Jan 09, 2023	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-23-002091.pdf 0001104659-23-002091.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Jan 05, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-23-000014.pdf 0001883850-23-000014.xls
Jan 05, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-23-000012.pdf 0001883850-23-000012.xls
Jan 05, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-23-000013.pdf 0001883850-23-000013.xls
Jan 05, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-23-000011.pdf 0001883850-23-000011.xls
Jan 05, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-23-000015.pdf 0001883850-23-000015.xls
Jan 05, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-23-000017.pdf 0001883850-23-000017.xls
Jan 05, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-23-000016.pdf 0001883850-23-000016.xls

Data provided by Kaleidoscope.

Investors & Media